✦ LIBER ✦

p53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer (NSCLC)

✍ Scribed by V. Gregorc; V. Ludovini; L. Pistola; S. Darwish; V. De Angelis; V. Minotti; G. Bellezza; A. Sidoni; E. Bucciarelli; M. Tonato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of p53 abnormalities in

✍ J. Niklinski; L. Chyczewski; W. Niklinska; J. Laudanski; M. Furman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Maintenance chemotherapy in advanced non

✍ Jacek Jassem 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 82 KB

Paclitaxel (P) plus carboplatin (C) in a

✍ Richardet, E; Cóppola, F; Jovtis, S; Fein, L; Uranga, G; Lewi, D; Ventriglia, M; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 260 KB

Weekly chemotherapy with irinotecan plus

✍ Rich, R.S; Argiris, A; Peccerillo, K; McKeon, A; Gallipoli, M; Burtness, B.A; Mu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

P-223 Decline in circulating cyfra predi

✍ Cafferata, Mara Argenide; Ardizzoni, Andrea; Paganuzzi, Michela; Marroni, Paola; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Relevance of p53, bcl-2 and Rb expressio

✍ Gregorc, Vanesa; Ludovini, Vienna; Pistola, Lorenza; Darwish, Samir; Floriani, I 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 284 KB